Inhibikase Developing Revolutionary Therapy to Reverse the Course of Parkinson’s Disease

Celebrated scientist and biotech entrepreneur Milton Werner believes that several key studies and recent research have revolutionized understanding of the biochemistry underlying the Parkinson’s disease process. In fact, his company, Inhibikase Therapeutics, Inc., is taking a risk-reducing approach to CNS drug development by leveraging established...

ConVERGEnce: How One Startup is Taking the Guesswork out of Drug Discovery Via Genomics

While training in the UCLA M.D./Ph.D. program in neuroscience, Alice Zhang made a keen decision to launch a genomics startup that would accelerate and lower the cost of the drug discovery process by combining innovation in neuroscience, machine learning, and genomics. That company, which she...

Canada Sees Biotech as Key Asset and Priority for its Economic Growth

While the US is recognized as the dominate player in the global biotech sector, its Canadian neighbor to the north also recognizes the strategic importance of biotech as a key economic driver for the country, and its critical role in the economy. Helping to...

Michael J. Fox Foundation CEO Sees ‘Significant Progress’ in Treating Causes of Parkinson’s Disease

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) invests nearly 90% of its spending to find a cure for the debilitating neurodegenerative disease, totaling more than $800 million since its founding in 2000, including $100 million in 2017. MJFF CEO Todd Sherer, Ph.D., notes...

Prothena Seeking to Develop Therapies to Block Underlying Cause of Parkinson’s Diseas

While people are living longer, it also means they are also susceptible to aging diseases. Parkinson's disease is a progressive degenerative disorder of the central nervous system (CNS) that affects one in 100 people over age 60. With an estimated seven to 10 million...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Historic Approvals Highlighted at the Second China Innovative Drug Ecosystem Forum...

The recent China Innovative Drug Ecosystem Forum, organized by STA Pharmaceutical, a WuXi AppTec company (WuXi STA), was a resounding success with apt timing...